Literature DB >> 25177479

Chronic obstructive pulmonary disease exacerbations: latest evidence and clinical implications.

Hammad Qureshi1, Amir Sharafkhaneh2, Nicola A Hanania3.   

Abstract

Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality worldwide and results in an economic and social burden that is both substantial and increasing. The natural history of COPD is punctuated by exacerbations which have major short- and long-term implications on the patient and healthcare system. Evidence-based guidelines stipulate that early detection and prompt treatment of exacerbations are essential to ensure optimal outcomes and to reduce the burden of COPD. Several factors can identify populations at risk of exacerbations. Implementing prevention measures in patients at risk is a major goal in the management of COPD.

Entities:  

Keywords:  bronchodilators; chronic bronchitis; chronic obstructive pulmonary disease; emphysema; exacerbation; prevention; treatment

Year:  2014        PMID: 25177479      PMCID: PMC4131503          DOI: 10.1177/2040622314532862

Source DB:  PubMed          Journal:  Ther Adv Chronic Dis        ISSN: 2040-6223            Impact factor:   5.091


  92 in total

Review 1.  Effect of long-acting beta-agonists on the frequency of COPD exacerbations: a meta-analysis.

Authors:  J Wang; B Nie; W Xiong; Y Xu
Journal:  J Clin Pharm Ther       Date:  2011-07-11       Impact factor: 2.512

2.  Exacerbation of respiratory symptoms in COPD patients may not be exacerbations of COPD.

Authors:  Bianca Beghé; Alessia Verduri; Mihai Roca; Leonardo M Fabbri
Journal:  Eur Respir J       Date:  2013-04       Impact factor: 16.671

3.  Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial.

Authors:  P S Burge; P M Calverley; P W Jones; S Spencer; J A Anderson; T K Maslen
Journal:  BMJ       Date:  2000-05-13

4.  High doses of vitamin D to reduce exacerbations in chronic obstructive pulmonary disease: a randomized trial.

Authors:  An Lehouck; Chantal Mathieu; Claudia Carremans; Femke Baeke; Jan Verhaegen; Johan Van Eldere; Brigitte Decallonne; Roger Bouillon; Marc Decramer; Wim Janssens
Journal:  Ann Intern Med       Date:  2012-01-17       Impact factor: 25.391

5.  Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study.

Authors:  N R Anthonisen; J E Connett; J P Kiley; M D Altose; W C Bailey; A S Buist; W A Conway; P L Enright; R E Kanner; P O'Hara
Journal:  JAMA       Date:  1994-11-16       Impact factor: 56.272

6.  Tobramycin Nebulizer Solution in severe COPD patients colonized with Pseudomonas aeruginosa: effects on bronchial inflammation.

Authors:  Roberto Dal Negro; Claudio Micheletto; Silvia Tognella; Marilia Visconti; Claudio Turati
Journal:  Adv Ther       Date:  2008-10       Impact factor: 3.845

7.  Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials.

Authors:  Peter M A Calverley; Klaus F Rabe; Udo-Michael Goehring; Søren Kristiansen; Leonardo M Fabbri; Fernando J Martinez
Journal:  Lancet       Date:  2009-08-29       Impact factor: 79.321

8.  Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease.

Authors:  G C Donaldson; T A R Seemungal; A Bhowmik; J A Wedzicha
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139

9.  Controlled clinical trial of methylprednisolone in patients with chronic bronchitis and acute respiratory insufficiency.

Authors:  R K Albert; T R Martin; S W Lewis
Journal:  Ann Intern Med       Date:  1980-06       Impact factor: 25.391

10.  Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial.

Authors:  Sanjay Sethi; Paul W Jones; Marlize Schmitt Theron; Marc Miravitlles; Ethan Rubinstein; Jadwiga A Wedzicha; Robert Wilson
Journal:  Respir Res       Date:  2010-01-28
View more
  46 in total

1.  Adherence and healthcare utilization among older adults with COPD and depression.

Authors:  Jennifer S Albrecht; Bilal Khokhar; Ting-Ying Huang; Yu-Jung Wei; Ilene Harris; Patience Moyo; Peter Hur; Susan W Lehmann; Giora Netzer; Linda Simoni-Wastila
Journal:  Respir Med       Date:  2017-06-03       Impact factor: 3.415

Review 2.  Pathobiological mechanisms underlying metabolic syndrome (MetS) in chronic obstructive pulmonary disease (COPD): clinical significance and therapeutic strategies.

Authors:  Stanley M H Chan; Stavros Selemidis; Steven Bozinovski; Ross Vlahos
Journal:  Pharmacol Ther       Date:  2019-02-26       Impact factor: 12.310

Review 3.  Digital health for COPD care: the current state of play.

Authors:  Hang Ding; Farhad Fatehi; Andrew Maiorana; Nazli Bashi; Wenbiao Hu; Iain Edwards
Journal:  J Thorac Dis       Date:  2019-10       Impact factor: 2.895

4.  In vitro study of the role of FOXO transcription factors in regulating cigarette smoke extract-induced autophagy.

Authors:  Prathyusha Bagam; Gagandeep Kaur; Dhirendra Pratap Singh; Sanjay Batra
Journal:  Cell Biol Toxicol       Date:  2020-11-02       Impact factor: 6.691

5.  Secondhand Smoke Induces Inflammation and Impairs Immunity to Respiratory Infections.

Authors:  Tariq A Bhat; Suresh Gopi Kalathil; Paul N Bogner; Austin Miller; Paul V Lehmann; Thomas H Thatcher; Richard P Phipps; Patricia J Sime; Yasmin Thanavala
Journal:  J Immunol       Date:  2018-03-19       Impact factor: 5.422

6.  Hepcidin Is Essential for Alveolar Macrophage Function and Is Disrupted by Smoke in a Murine Chronic Obstructive Pulmonary Disease Model.

Authors:  Elizabeth Perez; Jonathan R Baker; Silvana Di Giandomenico; Pouneh Kermani; Jacqueline Parker; Kihwan Kim; Jianjun Yang; Peter J Barnes; Sophie Vaulont; Joseph M Scandura; Louise E Donnelly; Heather Stout-Delgado; Suzanne M Cloonan
Journal:  J Immunol       Date:  2020-09-21       Impact factor: 5.422

Review 7.  Statins versus placebo for people with chronic obstructive pulmonary disease.

Authors:  Aisling Walsh; Lucy Perrem; Ali S Khashan; Michael T Henry; Muireann Ni Chroinin
Journal:  Cochrane Database Syst Rev       Date:  2019-07-31

8.  Cost-Effectiveness of Domiciliary High Flow Nasal Cannula Treatment in COPD Patients with Chronic Respiratory Failure.

Authors:  Sabrina Storgaard Sørensen; Line Hust Storgaard; Ulla Møller Weinreich
Journal:  Clinicoecon Outcomes Res       Date:  2021-06-18

9.  Clinical Audit on Chronic Obstructive Pulmonary Disease (COPD) Management in Primary Care: A Quality Improvement Project from Hong Kong.

Authors:  Xiao Rui Catherine Chen; Sau Nga Fu; Wing Kit Leung; Sze Wing Catherine Ng; Wing Yan Wendy Kwan; Tseng Kwong Wong; Pang Fai Chan; Man Ying Michelle Wong; Wai Kit Welchie Ko; Jun Liang; Ming Tung Eric Hui; Yim Chu Li; Wan Luk; V K David Chao
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-06-23

10.  Caregiver Experiences and Roles in Care Seeking During COPD Exacerbations: A Qualitative Study.

Authors:  Madhuvanthi Suresh; Jessica Young; Vincent Fan; Carol Simons; Catherine Battaglia; Tracy L Simpson; John C Fortney; Emily R Locke; Ranak Trivedi
Journal:  Ann Behav Med       Date:  2022-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.